These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 25044253)

  • 21. Assessing eligibility for lung cancer screening using parsimonious ensemble machine learning models: A development and validation study.
    Callender T; Imrie F; Cebere B; Pashayan N; Navani N; van der Schaar M; Janes SM
    PLoS Med; 2023 Oct; 20(10):e1004287. PubMed ID: 37788223
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Declining FEV1 and chronic productive cough in cigarette smokers: a 25-year prospective study of lung cancer incidence in Tecumseh, Michigan.
    Islam SS; Schottenfeld D
    Cancer Epidemiol Biomarkers Prev; 1994 Jun; 3(4):289-98. PubMed ID: 8061576
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protective effect of bisphosphonates on endometrial cancer incidence in data from the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial.
    Alford SH; Rattan R; Buekers TE; Munkarah AR
    Cancer; 2015 Feb; 121(3):441-7. PubMed ID: 25533883
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Randomization to screening for prostate, lung, colorectal and ovarian cancers and thyroid cancer incidence in two large cancer screening trials.
    O'Grady TJ; Kitahara CM; DiRienzo AG; Boscoe FP; Gates MA
    PLoS One; 2014; 9(9):e106880. PubMed ID: 25192282
    [TBL] [Abstract][Full Text] [Related]  

  • 25. OWL: an optimized and independently validated machine learning prediction model for lung cancer screening based on the UK Biobank, PLCO, and NLST populations.
    Pan Z; Zhang R; Shen S; Lin Y; Zhang L; Wang X; Ye Q; Wang X; Chen J; Zhao Y; Christiani DC; Li Y; Chen F; Wei Y
    EBioMedicine; 2023 Feb; 88():104443. PubMed ID: 36701900
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Italian cancer figures, report 2013: Multiple tumours.
    AIRTUM Working Group
    Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selecting High-Risk Individuals for Lung Cancer Screening: A Prospective Evaluation of Existing Risk Models and Eligibility Criteria in the German EPIC Cohort.
    Li K; Hüsing A; Sookthai D; Bergmann M; Boeing H; Becker N; Kaaks R
    Cancer Prev Res (Phila); 2015 Sep; 8(9):777-85. PubMed ID: 26076698
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence of a healthy volunteer effect in the prostate, lung, colorectal, and ovarian cancer screening trial.
    Pinsky PF; Miller A; Kramer BS; Church T; Reding D; Prorok P; Gelmann E; Schoen RE; Buys S; Hayes RB; Berg CD
    Am J Epidemiol; 2007 Apr; 165(8):874-81. PubMed ID: 17244633
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prostate Cancer Screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: findings from the initial screening round of a randomized trial.
    Andriole GL; Levin DL; Crawford ED; Gelmann EP; Pinsky PF; Chia D; Kramer BS; Reding D; Church TR; Grubb RL; Izmirlian G; Ragard LR; Clapp JD; Prorok PC; Gohagan JK;
    J Natl Cancer Inst; 2005 Mar; 97(6):433-8. PubMed ID: 15770007
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comorbidities, smoking status, and life expectancy among individuals eligible for lung cancer screening.
    Howard DH; Richards TB; Bach PB; Kegler MC; Berg CJ
    Cancer; 2015 Dec; 121(24):4341-7. PubMed ID: 26372542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between smoking and risk of bladder cancer among men and women.
    Freedman ND; Silverman DT; Hollenbeck AR; Schatzkin A; Abnet CC
    JAMA; 2011 Aug; 306(7):737-45. PubMed ID: 21846855
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bladder cancer screening in a high risk asymptomatic population using a point of care urine based protein tumor marker.
    Lotan Y; Elias K; Svatek RS; Bagrodia A; Nuss G; Moran B; Sagalowsky AI
    J Urol; 2009 Jul; 182(1):52-7; discussion 58. PubMed ID: 19450825
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantified relations between exposure to tobacco smoking and bladder cancer risk: a meta-analysis of 89 observational studies.
    van Osch FH; Jochems SH; van Schooten FJ; Bryan RT; Zeegers MP
    Int J Epidemiol; 2016 Jun; 45(3):857-70. PubMed ID: 27097748
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Smoking knowledge assessment and cessation trends in patients with bladder cancer presenting to a tertiary referral center.
    Guzzo TJ; Hockenberry MS; Mucksavage P; Bivalacqua TJ; Schoenberg MP
    Urology; 2012 Jan; 79(1):166-71. PubMed ID: 22030373
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Flexible sigmoidoscopy in the PLCO cancer screening trial: results from the baseline screening examination of a randomized trial.
    Weissfeld JL; Schoen RE; Pinsky PF; Bresalier RS; Church T; Yurgalevitch S; Austin JH; Prorok PC; Gohagan JK;
    J Natl Cancer Inst; 2005 Jul; 97(13):989-97. PubMed ID: 15998952
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adherence to the Diabetes Risk Reduction Diet and Bladder Cancer Risk in the Prostate, Lung, Colorectal, Ovarian (PLCO) Cohort.
    Chen Y; Zeng S; Jiao B; Zhang H; Li G; Zhang X; Hu X
    Cancer Epidemiol Biomarkers Prev; 2023 Dec; 32(12):1726-1733. PubMed ID: 37721479
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term outcome of hematuria home screening for bladder cancer in men.
    Messing EM; Madeb R; Young T; Gilchrist KW; Bram L; Greenberg EB; Wegenke JD; Stephenson L; Gee J; Feng C
    Cancer; 2006 Nov; 107(9):2173-9. PubMed ID: 17029275
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tobacco use and bladder cancer patterns in three western European countries.
    Van Hemelrijck MJ; Michaud DS; Connolly GN; Kabir Z
    J Public Health (Oxf); 2009 Sep; 31(3):335-44. PubMed ID: 19567475
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Second primary lung cancer in United States Cancer Survivors, 1992-2008.
    Donin NM; Kwan L; Lenis AT; Drakaki A; Chamie K
    Cancer Causes Control; 2019 May; 30(5):465-475. PubMed ID: 30900065
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Occupation and cancer - follow-up of 15 million people in five Nordic countries.
    Pukkala E; Martinsen JI; Lynge E; Gunnarsdottir HK; Sparén P; Tryggvadottir L; Weiderpass E; Kjaerheim K
    Acta Oncol; 2009; 48(5):646-790. PubMed ID: 19925375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.